Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Mucosal healing is not associated with better outcome during 7 years of follow-up in pediatric patients with Crohn's disease

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F24%3A10442427" target="_blank" >RIV/00179906:_____/24:10442427 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00216208:11150/24:10442427

  • Výsledek na webu

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=hgXl1WVpL7" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=hgXl1WVpL7</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.23736/S2724-5276.21.06099-0" target="_blank" >10.23736/S2724-5276.21.06099-0</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Mucosal healing is not associated with better outcome during 7 years of follow-up in pediatric patients with Crohn's disease

  • Popis výsledku v původním jazyce

    Background: Mucosal healing (MH) has become a perspective treatment target in patients with Crohn&apos;s disease (CD). Data about the impact of MH on long-term outcome in pediatric patients are still scarce. Methods: 76 pediatric patients with CD were evaluated retrospectively (2000-2015) in a tertiary care center. Based on MH achievement, they were divided into two groups (MH, n= 17; and No MH, n=59). The primary endpoint was to assess the association of MH and the need for CD-related hospitalizations or surgery in pediatric patients with CD. Results: The number of hospitalized patients was 24% in the MH group and 42% in the No MH group, P = 0.26. The total number of CD-related hospitalizations was not significant between the MH group and the No MH group (5 vs. 41, P = 0.15). The time to the first hospitalization was 24 months in MH and 21 months in No MH, P&gt;0.99. 24% patients in the MH group and 39% patients in the No MH group underwent CD-related operation, P = 0.39. Time to the first operation was 43 months for MH and 19 months for the No MH group, P = 0.13. The follow-up period was 91 months in the MH group and 80 months in the No MH group, P = 0.74. The use of infliximab was positively associated with MH, P = 0.002. Conclusions: MH was not associated with fewer CD-related hospitalizations or operations in pediatric patients with CD during seven years of follow-up.

  • Název v anglickém jazyce

    Mucosal healing is not associated with better outcome during 7 years of follow-up in pediatric patients with Crohn's disease

  • Popis výsledku anglicky

    Background: Mucosal healing (MH) has become a perspective treatment target in patients with Crohn&apos;s disease (CD). Data about the impact of MH on long-term outcome in pediatric patients are still scarce. Methods: 76 pediatric patients with CD were evaluated retrospectively (2000-2015) in a tertiary care center. Based on MH achievement, they were divided into two groups (MH, n= 17; and No MH, n=59). The primary endpoint was to assess the association of MH and the need for CD-related hospitalizations or surgery in pediatric patients with CD. Results: The number of hospitalized patients was 24% in the MH group and 42% in the No MH group, P = 0.26. The total number of CD-related hospitalizations was not significant between the MH group and the No MH group (5 vs. 41, P = 0.15). The time to the first hospitalization was 24 months in MH and 21 months in No MH, P&gt;0.99. 24% patients in the MH group and 39% patients in the No MH group underwent CD-related operation, P = 0.39. Time to the first operation was 43 months for MH and 19 months for the No MH group, P = 0.13. The follow-up period was 91 months in the MH group and 80 months in the No MH group, P = 0.74. The use of infliximab was positively associated with MH, P = 0.002. Conclusions: MH was not associated with fewer CD-related hospitalizations or operations in pediatric patients with CD during seven years of follow-up.

Klasifikace

  • Druh

    J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS

  • CEP obor

  • OECD FORD obor

    30209 - Paediatrics

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2024

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Minerva Pediatrics

  • ISSN

    2724-5276

  • e-ISSN

    2724-5780

  • Svazek periodika

    76

  • Číslo periodika v rámci svazku

    3

  • Stát vydavatele periodika

    IT - Italská republika

  • Počet stran výsledku

    7

  • Strana od-do

    381-387

  • Kód UT WoS článku

  • EID výsledku v databázi Scopus

    2-s2.0-85195435814